An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression

AIMS: Currently, no head-to-head data are available comparing semaglutide 2.0 mg with dulaglutide 3.0 mg or 4.5 mg. We conducted an indirect treatment comparison (ITC) of their effects on glycated hemoglobin (HbA(1c)) and body weight in patients with type 2 diabetes. MATERIALS AND METHODS: Multileve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lingvay, Ildiko, Bauer, Robert, Baker-Knight, James, Lawson, Jack, Pratley, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Meta-Analyses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016460/
https://www.ncbi.nlm.nih.gov/pubmed/34922383
http://dx.doi.org/10.1210/clinem/dgab905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016460/
https://www.ncbi.nlm.nih.gov/pubmed/34922383
http://dx.doi.org/10.1210/clinem/dgab905

Ejemplares similares